Welcome : Guest

Novartis AG (Switzerland) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Novartis AG, which is principally involved in providing Healthcare Solutions. Illustrated with 193 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-00028
Price: $3500
Company Type: Public
Pages: 208
Date: January 2017
Market Data Tables: 193

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Novartis AG’s Sales by Business Segment Worldwide (2014-2015) in Percentage for Pharmaceuticals Division, Alcon Division, and Sandoz Division......14
Table 2: Novartis AG’s Sales by Country Worldwide (2014-2015) in Percentage for Switzerland, United States, United Kingdom, Germany, France, Japan, and Others......15
Table 3: Novartis AG’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for Europe, Americas, and Asia/Africa/Australasia......16
Pharmaceuticals......18
Table 4: Pharma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Injectables, Oral Solids, Tropicals and Others......18
Table 5: Pharmaceutical Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for China, Japan, USA and Others......19
Table 6: Pharmaceuticals Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia, Africa, and Australasia, European Union, Japan, Latin America, and North America......20
Table 7: Pharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Generic, Originator Brand, and Others......21
Table 8: Pharmaceuticals Sales by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for Active Pharmaceutical Ingredients, Contrast Products, Radiopharmaceuticals, and Specialty Pharmaceuticals......22
Table 9: Pharmaceuticals Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics and Chemical Synthetic and Others......23
Table 10: New Pharmaceutical Licensed Drugs Market by Indication Worldwide (2015) - Percentage Share Breakdown by Value Sales for AIDS, Diabetes, Diabetes (DPP4), Hepatitis B, Hypertension, and Others......24
Table 11: New Pharmaceutical Licensed Drugs Market by Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Humulin, Trajenta, Truvada, Twynsta, Viread, and Others......25
Table 12: Emerging Market Pharma Sales by Country Worldwide (2015) - Percentage Share Breakdown by Value Sales for Africa & Middle East, Brazil, China, India, Russia, and Others......26
Table 13: Research & Development Spending in Pharmaceuticals by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for Approval, Discovery, Pre-Clinical, Phase I, Phase II, Phase III, Phase IV, and Others......27
Table 14: Pharmaceutical Consumption by Category in Australia (2015) - Percentage Share Breakdown for Aged over 65 Years, and Aged under 65 Years......28
Table 15: Pharmaceutical Market by Region in Brazil (2015) - Percentage Share Breakdown by Value Sales for Mid-West, North, Northeast, São Paulo, South, and Others......29
Table 16: Pharmaceutical Sales by Category in Brazil (2015) - Percentage Share Breakdown by Value for Generics, Over the Counter (OTC) Drugs, and Prescription......30
Table 17: Pharmaceutical Market by Category in Canada (2015) - Percentage Share Breakdown by Value for Hospital and Retail......31
Table 18: Pharmaceutical Distribution Market by Region in China (2015) - Percentage Share Breakdown by Value for Eastern China, North East China, Northern China, Northwestern China, Southern China, and Southwestern China......32
Table 19: Pharmaceuticals Market by Therapeutic Area in China (2015) - Percentage Share Breakdown by Value Sales for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular Diseases, Musculo-Skeletal System, Nervous System, Oncology, Respiratory System, Systemic Anti- Infective, and Others......33
Table 20: Pharmaceutical Market by Country in Europe (2015) - Percentage Share Breakdown by Value Sales for France, Germany, Greece, Italy, Spain, UK, and Others......34
Table 21: Pharmaceutical Drugs Market by Category in Germany (2015) - Percentage Share Breakdown by Value Sales for Biopharmaceuticals, Pharma Drugs for Human Use, and Others......35
Table 22: Pharma Market by Category in Indonesia (2015) - Percentage Share Breakdown by Value for Branded Generics and Licensed, Over the Counter and Unbranded Generics......36
Table 23: Pharmaceutical Market by Region in Latin America (2015) - Percentage Share Breakdown by Value for Argentina, Brazil, Mexico, Venezuela and Others......37
Table 24: Retail Pharmaceutical Market by Type in Mexico (2015) - Percentage Share Breakdown by Value for Private Market and Public Market......38
Table 25: Spending on Pharmaceutical by Category in Nigeria (2015) - Percentage Share Breakdown by Value for Generic Drug Sales, Over-The-Counter Medicine Sales and Patented Drug Sales......39
Table 26: Private Pharmaceuticals Market by Segment in South Africa (2015) - Percentage Share Breakdown by Value for Branded and Ethical, Generic, Over the Counter and Others......40
Table 27: Pharmaceutical Drugs Manufacturers by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Biological Products, Medicinal and Botanical Products, Oncological Products, and Others......41
Table 28: Speciality Pharmaceuticals Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Anti-Coagulant, Growth Hormone, Hepatitis C, HIV/AIDS (incl oral solids), IVIG/Hemophilia, Macular Degeneration, Multiple Sclerosis, Oncology (incl. oral solids), Pulmonary Arterial Hypertension, Renal, Rheumatoid arthritis/Chrohn's, Transplant, and Others......42
Table 29: Pharmaceutical Market by Category in Vietnam (2015) - Percentage Share Breakdown by Value for Generic Drugs, Patented Drugs and Others......43
Immunology......44
Table 30: Immunology Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Dermatology, Gastroenterology, and Rheumatology......44
Respiratory Drugs......45
Table 31: Respiratory Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue, and Rhinitis......45
Table 32: Respiratory Therapeutic Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue and Rhinitis......46
Cancer......47
Table 33: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......47
Table 34: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others......48
Table 35: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......49
Table 36: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......50
Table 37: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......51
Table 38: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......52
Table 39: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......53
Table 40: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......54
Table 41: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......55
Table 42: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......56
Table 43: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......57
Table 44: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......58
Table 45: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......59
Table 46: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......60
Bladder Cancer......61
Table 47: No. of Bladder Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......61
Breast Cancer......62
Table 48: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......62
Cervical Cancer......63
Table 49: Cervical Cancer Market by HPV Type in England (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 33, HPV 45, and Others......63
Table 50: Cervical Cancer Market by HPV Type in Europe (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 31, HPV 33, and Others......64
Colorectal Cancer......65
Table 51: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......65
Hematological Cancer......66
Table 52: Hematological Cancer by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......66
Invasive Breast Cancer......67
Table 53: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......67
Table 54: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......68
Primary Liver Cancer......69
Table 55: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......69
Skin Cancer......70
Table 56: Skin Cancer by Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......70
Cancer in Stage 3/4......71
Table 57: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......71
Solid Cancer Tumor Patients......72
Table 58: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......72
Cancer-Associated Mucositis......73
Table 59: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......73
Cancer Drugs......74
Table 60: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......74
Chronic Lymphocytic Leukemia (CLL)......75
Table 61: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......75
Table 62: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......76
Table 63: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......77
Chronic Myelogenous Leukemia (CML)......78
Table 64: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......78
Cutaneous Melanoma......79
Table 65: No. of Cutaneous Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......79
Ocular Melanoma......80
Table 66: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......80
Female Mortality......81
Table 67: Female Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......81
Male Mortality......82
Table 68: Male Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Colon, Rectum and Anus, Intestine, Liver, Lung, and Others......82
Nausea and Vomiting Associated With Cancer Chemotherapy......83
Table 69: Nausea and Vomiting Associated With Cancer Chemotherapy Market by Drug in European Union (2015) - Percentage Share Breakdown by Value for Aprepitant (Emend), Netupitant (Akynzeo), and Rolapitant (Varubi)......83
Multiple Myeloma......84
Table 70: Multiple Myeloma by Age Group Worldwide (2015) - Percentage Share Breakdown by No. of New Cases for 45-54, 55-64, 65-74, 75-84, >84, and Others......84
Table 71: Multiple Myeloma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kyprolis AMGN, Pomalyst CELG, Revlimid CELG, Thalomid CELG, and Velcade TKD/JNJ......85
Non Small Cell Lung Cancer Patients......86
Table 72: No. of Non Small Cell Lung Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I, Stage II-III, Stage III-IV, and Undiagnozed......86
Glaucoma Drugs......87
Table 73: Glaucoma Drugs Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonists (AA), Beta Blocker Fixed Combos (BB-FC), Beta Blockers (BB), Carboic Anhydrase Inhibitors (CAI) and Prostaglandins (PGA)......87
Glaucoma......88
Table 74: Glaucoma Disease Market for Prostaglandin Analogs (PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Latanoprost, Lumigan, Travatan and Others......88
Table 75: Glaucoma Disease Market for Non Prostaglandin Analogs (Non-PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blockers (alone), Beta Blockers (combo), Canbone Anymore and Others......89
Table 76: Glaucoma Market by Product in the US (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blocker, Beta Blocker Fixed Combo, Bimatoprost (Lumigan), Carbonic Anhydrase Inhibitor, Latanoprost (Xalatan, Generics), Travoprost (Travatan), and Others......90
Ophthalmic Drugs......91
Table 77: Ophthalmic Antibiotic Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Besivance, Moxeza, Vigamox, Zymaxid and Generic & Others......91
Table 78: Ophthalmic Steroid Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Alrex, Durezol, Lotemax, Ozurdex and Generic & Others......92
Allergy Drugs......93
Table 79: Allergy and Rhinitis Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Allegra and Telfast, Avamys and Veramyst, Claritin and Clarinex, Zyrtec and Xyzal, and Others......93
Table 80: Allergy Care Market by Category in the US (2015) - Percentage Share Breakdown by Value for Private-Label and Others......94
Table 81: US Market (Private Label and Others) by Product (2015) - Percentage Share Breakdown by Values Sales for Allergy Care, Baby Food, Bakery, Bleach, Dairy, Deodorants, Hair Care, Ice Cream, Laundry Care, Oral Care, OTC, Pet Food, Pet Products, Retail Tissue, Sauces/Dressing, Skin Care, Sun Care, Toilet Care and VDS......95
Biopharmaceuticals......96
Table 82: Biopharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Norditropin, NovoSeven, Turoctocog Alpha, and Others......96
Pharmaceuticals......97
Table 83: Market Shares of Leading Pharmaceutical Companies in Australia (2015) - Percentage Share Breakdown by Value for AstraZeneca, Pfizer, Inc. and Others......97
Table 84: Market Shares of Leading Pharmaceutical Distributors in Brazil (2015) - Percentage Share Breakdown by Value for Panpharma Participacoes S.A., Profarma Distribuidora de Produtos Farmaceuticos S.A., Santa Cruz and Other......98
Table 85: Market Shares of Leading Pharmaceutical Companies in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma Tbk., Pfizer Indonesia PT Tbk, Sanbe Farma PT, and Others......99
Table 86: Market Shares of Leading Pharmaceutical Suppliers to Hospitals in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma, Tbk, Sanbe Farma PT, Soho Group, and Others......100
Table 87: Market Shares of Leading Pharmaceutical Drugs Manufacturers in the US (2015) - Percentage Breakdown by Value for Amgen, Eli Lilly and Co., Johnson and Johnson Co, Merck & Co., Inc., Pfizer, Inc., and Others......101
Table 88: Market Shares of Leading Pharmaceutical Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Abbott Laboratories, Amgen Corporation, AstraZeneca Plc, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......102
Table 89: Market Shares of Leading Pharmaceutical Companies in India (2014) - Percentage Breakdown by Value for Abbott India Limited, Alembic Pharmaceuticals Limited, Alkem Laboratories, Aristo Pharmaceuticals Pvt Ltd., Cadila Pharmaceuticals Limited., Cipla Global Limited, Dr. Reddy's Laboratories., Emcure Pharmaceuticals Ltd., FDC Limited., GlaxoSmithKline Pharmaceuticals Ltd., Glenmark Pharmaceuticals, Intas Pharmaceuticals limited, Lupin Limited, Macleods Pharmaceuticals Ltd., Mankind Pharma, Micro Labs Ltd., Novartis AG, Pfizer Limited, India., Ranbaxy Laboratories Limited, Sanofi India Limited, Sun India Pharmacy (P) Ltd., Torrent Pharmaceuticals Limited., Unichem Laboratories, USV Limited., Wockhardt Ltd., and Others......103
Respiratory Therapeutics......104
Table 90: Market Shares of Leading Respiratory Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......104
Cancer Drugs......105
Table 91: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......105
Table 92: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......106
Table 93: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......107
Table 94: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......108
Table 95: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......109
Breast Cancer Drugs......110
Table 96: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......110
Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL)......111
Table 97: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......111
Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL)......112
Table 98: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......112
Table 99: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (R/R- aNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib and Others......113
Anti-Infectives......114
Table 100: Market Shares of Leading Anti-Infective Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Bayer AG, Merck & Co., Inc., Vétoquinol S.A., Virbac S.A., Zoetis, Inc. and Others......114
Allergy Care Products......115
Table 101: Market Shares of Leading Allergy Immunotherapy Treatment Providers Worldwide (2015) - Percentage Breakdown by Value for ALK-Abelló, Greer Laboratories, Inc., and Others......115
Table 102: Market Shares of Leading Allergy Immunotherapy Treatment Providers in the UK (2015) - Percentage Breakdown by Value for ALK, Allergopharma, Allergy Therapeutics, HAL Allergy, Leti/Novartis, Stallergenes, and Others......116
Table 103: Market Shares of Leading Allergy Care Product Companies by Value Sales in the US (2014) - Percentage Breakdown for Johnson & Johnson Inc., Merck & Co Inc., Novartis AG, Pfizer Inc., Prestige Brands Holdings Inc., Sanofi S A, Private Label and Others......117
Table 104: Allergy Drug Market in the UK (2015) - Percentage Share Breakdown by Value for Allegra, Allelock, Clarinex, Claritin, Zyrtec, and Others......118
Biopharmaceuticals......119
Table 105: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Ltd., Lonza Group Ltd., Pfizer, Inc., Sanofi S.A., and Others......119
Table 106: Market Shares of Leading Biopharmaceutical Companies in the US (2015) - Percentage Market Share Breakdown by Value for Actelion Pharmaceuticals Ltd., Alexion Pharmaceuticals, Inc., Celgene Corporation, Gilead Sciences, Inc., Incyte, Corporation, Isis Pharmaceuticals, Inc., Vertex Pharmaceuticals, Inc., and Others......120
Artemisinin-based Combination Therapies (ACT)......121
Table 107: Market Shares of Leading Artemisinin-based Combination Therapies (ACT) Manufacturers by Value Sales Worldwide (2015) - Percentage Breakdown for Ajanta Pharma Limited, Cipla Limited, Guilin Pharmaceutical Co., Ltd., Ipca Laboratories, Novartis AG, Quality Pharma Products Pvt Ltd., Sanofi S.A., and Sigma Pharmaceuticals Limited......121
Affordable Medicines Facility Malaria (AMFm)......122
Table 108: Market Shares of Leading Affordable Medicines Facility Malaria (AMFm) Manufacturers by Value Sales Worldwide (2015) - Percentage Breakdown for Ajanta Pharma Limited, Cipla Limited, Ipca Laboratories, Novartis AG, Strides Arcolab Limited, and Others......122
Molecular Diagnostics (MDx)......123
Table 109: Market Shares of Leading Molecular Diagnostics (MDx) Companies by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Co., Cepheid, F. Hoffmann-La Roche Ltd., Hologic Gen-Probe, Inc., Novartis AG, Qiagen N.V., Siemens AG and Others......123
Consumer Health Product......124
Table 110: Market Shares of Leading Consumer Health Product Producers by Value Sales in the US OTC Market (2014) - Percentage Breakdown for Bayer AG, GlaxoSmithKline Plc., Johnson & Johnson Inc., Merck & Co Inc., Novartis AG, Pfizer Inc., Prestige Brands Holdings Inc., Procter & Gamble Co., Reckitt Benckiser Plc., Sanofi S.A., Private Label and Others......124
Table 111: Market Shares of Leading Consumer Health Product Producers by Value Sales in the US (2014) - Percentage Breakdown for Bayer AG, General Nutrition Centres, Inc., Glanbia Plc, GlaxoSmithKline Plc, Herbalife Ltd., Johnson & Johnson, Inc., Living Essentials, LLC, Merck & Co, Inc., NBTY, Inc., Novartis AG, Otsuka Holdings Co., Ltd., Pfizer, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Reckitt Benckiser Plc, Sanofi SA, Private Label, and Others......125
Table 112: Market Shares of Leading Consumer Health Product Manufacturers in US (2015) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson Inc, Living Essentials, Merck & Co., Inc., NBTY, Inc., Novartis AG, Pfizer Inc, Procter & Gamble Co., Private-Label and Others......126
Vitamins & Dietary Supplements......127
Table 113: Market Shares of Leading Vitamins & Dietary Supplement Product Producers by Value Sales in the US (2014) - Percentage Breakdown for Bayer AG, General Nutrition Centres, Inc., GlaxoSmithKline Plc, Herbalife Ltd., Johnson & Johnson, Inc., Living Essentials, LLC, NBTY, Inc., Novartis AG, Otsuka Holdings Co., Ltd., Pfizer, Inc., Procter & Gamble Co., Private Label and Others......127
Herbal Products......128
Table 114: Market Shares of Leading Herbal Products Producers by Value Sales in the US (2014) - Percentage Breakdown for General Nutrition Centres, Inc., GlaxoSmithKline Plc, Herbalife Ltd., Johnson & Johnson, Inc., NBTY, Inc., Novartis AG, Pfizer, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Sanofi SA, Private Label and Others......128
Paediatric Health Products......129
Table 115: Market Shares of Leading Paediatric Health Product Companies by Value Sales in the US (2014) - Percentage Breakdown for Bayer AG, Herbalife Ltd., Johnson & Johnson Inc., Merck & Co Inc., NBTY Inc., Novartis AG, Pfizer Inc., Prestige Brands Holdings Inc., Procter & Gamble Co., Reckitt Benckiser Plc., Sanofi S A, Private Label and Others......129
Bone Diseases Therapeutic......130
Table 116: Market Shares of Leading Bone Diseases Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Amgen, Inc., Eli Lilly and Company, GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, Sanofi S.A., and Others......130
Cardiology Therapeutics......131
Table 117: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......131
Dermatology Therapeutics......132
Table 118: Market Shares of Leading Dermatology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Biogen Idec, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, and Others......132
Diabetes/Metabolic Therapeutics......133
Table 119: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......133
Epilepsy Therapeutics......134
Table 120: Market Shares of Leading Epilepsy Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......134
Infectious Disease Drugs......135
Table 121: Market Shares of Leading Infectious Disease Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol- Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......135
Multiple Sclerosis Therapeutics......136
Table 122: Market Shares of Leading Multiple Sclerosis Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Biogen Idec, Novartis AG, Sanofi S.A., and Others......136
Ophthalmology Therapeutics......137
Table 123: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......137
Rheumatology Therapeutic......138
Table 124: Market Shares of Leading Rheumatology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......138
Urinary Incontinence Therapeutic......139
Table 125: Market Shares of Leading Urinary Incontinence Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Eli Lilly and Company, Johnson & Johnson, Novartis AG, Pfizer, Inc., and Others......139
Therapeutic Providers......140
Table 126: Market Shares of Leading Therapeutic Providers (Alzheimer's Disease, Bone Diseases, Cardiology, CNS, Dermatology, Diabetes/Metabolic, Epilepsy, G.I./Ulcer, HBV/HCV, Infectious Disease, Multiple Sclerosis, Obesity, Onc./Hematology, Ophthalmology, Orphan Disease, Pain Management, Respiratory, Rheumatology, Sleep Disorders, Urinary Incont., and Women's Health) by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Biogen Idec, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Endo International Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......140
Osteoporosis, Hormone Replacement, & Cancer Bone Loss Medicine......141
Table 127: Market Shares of Leading Osteoporosis, Hormone Replacement, & Cancer Bone Loss Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Amgen, Inc. (AMGN), Eli Lilly And Co (LLY), Merck & Co., Inc. (MRK), Novartis AG (NVS), Sanofi SA (SNY), Warner Chilcott Plc (WCRX), and Others......141
Central Nervous System (CNS) Medicine......142
Table 128: Market Shares of Leading Central Nervous System Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc (AZN), Bristol-Myers Squibb Company (BMY), Eli Lilly And Co (LLY), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Novartis AG (NVS), Pfizer, Inc. (PFE), Shire Plc (SHPGY), and Others......142
Private Pharmaceutical......143
Table 129: Market Shares of Leading Private Pharmaceutical Companies in South Africa (2015) - Percentage Breakdown by Value for Adcock Ingram, Aspen Pharmacare Holdings Ltd., Cipla Ltd., Merck & Co., Inc., Novartis AG, Sanofi S.A., and Others......143
Generic Pharmaceutical......144
Table 130: Global IV Generics Drug Market by Value Sales (2015) - Percentage Share Breakdown for Fresenius Kabi AG, Hospira, Inc., Mylan, Inc., Novartis International AG, Teva Pharmaceutical Industries Ltd., and Others......144
Table 131: Market Shares of Leading Generic Injectable Drug Manufacturers Worldwide (2015) - Percentage Breakdown by Volume for Baxter International, Inc., Fresenius SE & Co. KGaA, Hikma Pharmaceuticals Plc, Hospira, Inc., Novartis AG, Pfizer, Inc., Sagent Pharmaceuticals, Inc., Sanofi S.A., and Other......145
Table 132: Market Shares of Leading Generics Manufacturers in Australia (2015) - Percentage Share Breakdown by Value for Apotex, Inc., Aspen Pharmaceutical Holdings Ltd., Mylan, Inc., Sandoz and Others......146
Table 133: Market Shares of Leading Generics Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Ems Sigma Pharma Group, Eurofarma Laboratórios, Hypermarcas S.A., Pfizer, Inc., Sanofi - Medley Indústria Farmacêutica Ltda and Others......147
Table 134: Market Shares of Leading Branded Generic Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Cimed Indústria Farmacêutica Ltda, Ems Sigma Pharma Group, Hypermarcas S.A., Pfizer, Inc., Takeda Pharmaceutical Company Limited, União Química Farmacêutica Nacional S.A and Others......148
Table 135: Market Shares of Leading Generic Pharmaceutical Companies by Value Sales in India (2014) - Percentage Breakdown for Abbott India Ltd., Alkem Laboratories Ltd., Cipla Ltd., GlaxoSmithKline Pharmaceuticals Ltd. (GSK), Lupin Ltd., Mankind Pharma, Pfizer Ltd., Ranbaxy Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Zydus Cadila and Others......149
Table 136: Market Shares of Leading Generics Manufacturers by Value Sales in South Africa (2014) - Percentage Breakdown for Adcock Ingram, Aspen Pharmacare Holdings Limited, Cipla Global Limited, Lupin Limited, Novartis International AG, Sanofi S.A., and Others......150
Table 137: Market Shares of Leading Generic Pharmaceutical Companies in South Africa (2015) - Percentage Breakdown by Value for Adcock Ingram, Aspen Pharmacare Holdings Ltd., Cipla Ltd., Daiichi Sankyo Company, Ltd., Lupin Ltd., Novartis AG, Servier Laboratories, and Others......151
Table 138: Market Shares of Leading Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Volume for Actavis plc, Mylan N.V., Sandoz, Teva Pharmaceutical Industries Ltd. and Others......152
Table 139: Market Shares of Leading Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Apotex, Inc., Dr. Reddy’s Laboratories Ltd. And GlaxoSmithKline......153
Table 140: Market Shares of Leading Derma Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Actavis plc, Perrigo Company plc, Sandoz, Taro Pharmaceutical Industries Ltd. and Others......154
Table 141: Market Shares of Leading Non-Branded Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Actavis, Mylan N.V., Teva Pharmaceutical Industries Ltd. and Others......155
Table 142: Market Shares of Leading Generic Injectable Drug Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Baxter International, Inc., Fresenius, Hospira, Inc., Novartis (Sandoz), and Others......156
Contact Lens......157
Table 143: Market Shares of Leading Contact Lens Manufacturers Worldwide (2015) - Percentage Breakdown by Value for B&L (Valeant Pharmaceuticals International, Inc.), CIBA (Novartis AG), Cooper Companies, Inc., Johnson & Johnson, and Others......157
Over-The-Counter (OTC)......158
Table 144: Market Shares of Leading Over-the-Counter (OTC) Product Manufacturers in US (2015) - Percentage Breakdown by Value for Bayer AG, GlaxoSmithKline Plc, Johnson & Johnson Inc, Merck & Co., Inc., Novartis AG, Pfizer Inc, Prestige Brands Holdings Inc, Procter & Gamble Co., Reckitt Benckiser Plc, Sanofi S.A., Private-Label and Others......158
Pediatric Health Product......159
Table 145: Market Shares of Leading Pediatric Health Product Manufacturers in the US (2015) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson Inc, Merck & Co., Inc., Novartis AG, Pfizer Inc, Prestige Brands Holdings Inc, Reckitt Benckiser Plc, Private-Label and Others......159
Parasiticides......160
Table 146: Market Shares of Leading Parasiticides Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Bayer AG, Merck & Co., Inc., Merial, Novartis AG, Zoetis, Inc. and Others......160
Medical Feed Additives......161
Table 147: Market Shares of Leading Medical Feed Additives Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Eli Lilly and Company, Merck & Co., Inc., Novartis AG, Zoetis, Inc. and Others......161
Injectable Drug......162
Table 148: Market Shares of Leading Injectable Drug Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co. KGaA, Hospira, Inc., Novartis AG, Pfizer, Inc., West-Ward Pharmaceuticals Corporation, and Others......162
Cough Syrup......163
Table 149: Market Shares of Leading Cough Syrup Manufacturers through Drug Store in the US (2015) - Percentage Breakdown by Value for Novartis AG, Pfizer, Inc., Procter & Gamble Co., ReckittBenckiser, Inc., and Others......163
DPP-4 Drugs......164
Table 150: Market Shares of Leading DPP-4 Drugs Manufacturers by Value Sales in China (2015) - Percentage Share Breakdown for Merck & Co., Inc., Novartis AG, and Others......164
Table 151: Market Shares of Leading DPP-4 Drug Brands in China (2015) - Percentage Share Breakdown by Value for Galvus, Januvia, Onglyza, and Others......165
DPP-4 Inhibitors......166
Table 152: Market Shares of Leading DPP-4 Inhibitors Manufacturers by Value Sales Worldwide (2015) - Percentage Share Breakdown for Merck & Co., Inc. (Januvia/Janumet), Novartis AG (Galvus/Galvumet) and Takeda Pharmaceutical Co., Ltd. (Nesina/Kezano), and Others......166
Pain Remedy Products......167
Table 153: Market Shares of Leading Pain Remedy Producers Sales in the US OTC Market (2014) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., Prestige Brands Holdings, Inc., Private Label and Others......167
Injectables......168
Table 154: Market Shares of Leading Injectable Manufacturers by Value Sales in Germany (2014) - Percentage Breakdown for AstraZeneca Plc, Baxter International, Inc., Fresenius SE & Co., Medac GmbH, Novartis International AG (Sandoz), Sanofi S.A.,Teva Pharmaceutical Industries Ltd. and Others......168
Table 155: Market Shares of Leading Injectable Manufacturers by Value Sales in France (2014) - Percentage Breakdown for Aguettant Limited, Baxter International, Inc., B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., Lake Forest Park Medical Clinic (LFP), Mylan Laboratories, Inc., Novartis International AG (Sandoz), Laboratoires PANPHARMA S.A., Sanofi S.A., and Others......169
Table 156: Market Shares of Leading Injectable Manufacturers by Value Sales in Italy (2014) - Percentage Breakdown for F. Hoffmann-La Roche Ltd., Hospira, Inc., Johnson & Johnson, KEDRION GROUP S.p.A., Novartis International AG (Sandoz), Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd. and Others......170
Vaccines......171
Table 157: Market Shares of Leading Vaccine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc (GSK), Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......171
Contact Lens......172
Table 158: Market Shares of Leading Contact Lens Manufacturers in the US (2015) - Percentage Breakdown by Value for CooperVision, Inc., Johnson & Johnson, Novartis International AG (CIBA), and Others......172
Injectable Miotics......173
Table 159: Market Shares of Leading Injectable Miotics Manufacturers in the US (2015) - Percentage Breakdown by Value for Alcon Incorporated, and Novartis International AG......173
Ophthalmic Equipment......174
Table 160: Market Shares of Leading Ophthalmic Equipment Providers Worldwide (2015) - Percentage Breakdown by Value for Bausch & Lomb Incorporated, Essilor International SA, Hoya Corporation, Johnson & Johnson, Novartis International AG, and Others......174
Letrozole......175
Table 161: Market Shares of Leading Letrozole Companies Worldwide (2014) - Percentage Share Breakdown by Value for Jiangsu Hengrui Medicine Co., Ltd., and Novartis International AG......175
Prescription Pharmaceutical......176
Table 162: Market Shares of Leading Prescription Pharmaceutical Companies in the US (2014) - Percentage Market Share Breakdown by Volume Sales for Actavis Plc, Amneal, Inc., Endo Pharma, Inc., Lupin Pharmaceuticals, Inc., Mylan Labs,Inc., Novartis International AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and Others......176
Alzheimer Disease Therapeutic......177
Table 163: Market Shares of Leading Alzheimer Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Forest Laboratories, Inc., Johnson & Johnson, Novartis International AG, Pfizer, Inc., and Others......177
Consumer Health......178
Table 164: Market Shares of Leading Consumer Health Product Producers Worldwide (2015) - Percentage Breakdown by Value for Bayer AG, GSK Pharmaceuticals Ltd. and Novartis International AG, Johnson & Johnson, Private Label, and Others......178
Antihypertensive Drugs......179
Table 165: Market Shares of Leading Antihypertensive Drugs Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for AstraZeneca, Bayer AG, Novartis International AG, Pfizer, Inc., Sanofi-Aventis and Others......179
Molecular Diagnostics (MDx)......180
Table 166: Market Shares of Leading Molecular Diagnostic Product Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Abbott Laboratories, Bayer AG, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Hologic Corporation, Novartis International AG, Qiagen, and Others......180
Irinotecan......181
Table 167: Market Shares of Leading Irinotecan Manufacturers in the US (2015) - Percentage Breakdown by Value for APP Pharmaceuticals, Inc., Hospira, Inc., Novartis International AG, Pfizer, Inc. and Teva Pharmaceutical Industries Ltd.......181
Human Growth Hormones (HGH)......182
Table 168: Market Shares of Leading Human Growth Hormones (HGH) Producers in the US (2015) - Percentage Breakdown by Value for Eli Lilly and Company, Genentech, Inc. and Roche Holding AG, Merck KGaA, Novartis International AG, Novo Nordisk A/S, Pfizer, Inc. and Teva Pharmaceutical Industries Ltd.......182
IV Generics Drug......183
Table 169: Market Shares of Leading IV Generic Drugs Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Baxter International, Inc., Fresenius Kabi AG, Hospira, Inc., Novartis International AG, Sun Pharmaceutical Industries Limited and Others......183
Prescription Drug......184
Table 170: Market Shares of Leading Prescription Drug Companies in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries, Ltd., and Others......184
Table 171: Market Shares of Leading Prescription Drug Companies Spending through Media Ads in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......185
Hepatitis B Drug......186
Table 172: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bemis Company, Inc.(Baraclude), F. Hoffmann-La Roche AG (Pegasys), GlaxoSmithKline Plc (Hepsera, Zeffix), and Novartis International AG (Sebivo)......186
Table 173: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales in Korea (2014) - Percentage Breakdown for Bemis Company, Inc. (BMS), Bukwang Pharmaceutical Co., Ltd (Levovir), GlaxoSmithKline Plc (Hopsera, Zeffix), Novartis International AG (Sebivo), and Others......187
Over the Counter Drugs......188
Table 174: Market Shares of Leading Over the Counter Drugs Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline-Novartis International AG, Johnson & Johnson and Others......188
Companion Animal......189
Table 175: Market Shares of Leading Pharmaceutical Companies for Companion Animal Worldwide (2015) - Percentage Breakdown by Value for Bayer AG, Merck & Co., Inc., Merial, Novartis AG, Zoetis, Inc. and Other......189
Pig Pharmaceutical......190
Table 176: Market Shares of Leading Pharmaceutical Companies for Pigs Worldwide (2015) - Percentage Breakdown by Value for Boehringer Ingelheim GmbH, Eli Lilly and Company, Merck & Co., Inc., Novartis AG, Zoetis, Inc. and Other......190
Sheep Pharmaceutical......191
Table 177: Market Shares of Leading Pharmaceutical Companies for Sheep Worldwide (2015) - Percentage Breakdown by Value for Ceva, Merck & Co., Inc., Merial, Novartis AG, Zoetis, Inc. and Others......191
Table 178: Novartis AG’s Sales by Business Segment (2015) - Percentage Share Breakdown by Value for Alcon, Consumer Health, Pharmaceuticals, Sandoz, and Vaccines and Diagnostics......192
Table 179: Novartis AG’s Sales by Type (2015) - Percentage Share Breakdown by Value for Pipeline Drugs, Strategic Drugs, and Tail Products......193
Table 180: Novartis International AG's Animal Health Sales by Region Worldwide (2015) - Percentage Share Breakdown by Value for United States and Rest of the World......194
Table 181: Novartis International AG's Animal Health Sales by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Companion and Livestock......195
Table 182: Novartis International AG’s Vaccine Sales by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Europe, United States, and Rest of World......196
Table 183: Novartis AG's Neuroscience & Ophthalmics Segment Sales by Drug (2015) - Percentage Share Breakdown by Volume for Exelon & Exelon Patch, Extavia, Gilenya, Lucentis, and Others......197
Table 184: Novartis AG’s Pharmaceutical Sales by Therapeutic Area (2015) - Percentage Share Breakdown by Value for Additional Products, Cardiovascular & Metabolism, Integrated Hospital Care, Neuroscience & Ophthalmics, Oncology, and Respiratory......198
Table 185: Novartis AG’s Cardiovascular & Metabolism Segment Sales by Drug (2015) - Percentage Share Breakdown by Volume for Diovan, Exforge, Galvus, Tekturna & Rasilez, and Others......199
Table 186: Novartis AG’s Oncology Segment Sales by Drug (2015) - Percentage Share Breakdown by Volume for Afinitor, Exjade, Gleevec & Glivec, Sandostatin, Tasigna, and Others......200
Table 187: Novartis AG’s Respiratory Segment Sales by Drug (2015) - Percentage Share Breakdown by Volume for NVA237, Onbrez Breezhaler & Arcapta Neohaler, QVA149, TOBI (Tobramycin), Xolair, and Others......201
Table 188: Novartis AG’s Integrated Hospital Care Segment Sales by Drug (2015) - Percentage Share Breakdown by Volume for ACZ885, Ilaris, Myfortic, Neoral & Sandimmun, Zortress & Certican, and Others......202
Table 189: Novartis AG’s Strategic Drugs Sales by Product (2015) - Percentage Share Breakdown by Volume for Afinitor & Votubia, Galvus, Gilenya, Gleevec & Glivec, Lucentis, and Others......203
Table 190: Novartis AG’s Tail products Sales by Drug Type (2015) - Percentage Share Breakdown by Volume for Ritalin & Focalin, Tegretol, Trileptal, Voltaren, and Others......204
Table 191: Novartis AG’s Pipeline Drugs Sales by Product (2015) - Percentage Share Breakdown by Volume for ACZ885, INC424 (JAK2 inh.), NVA237, QVA149, SOM230, and Others......205
Table 192: Novartis AG’s Sales by Geographic Region Worldwide (2013) in Percentage for Switzerland, United States, Germany, Japan, France, and Others......206
Table 193: Novartis AG’s Sales by Product Segment Worldwide (2011-2013) in US$ Million for Pharmaceuticals, Alcon, Sandoz, Vaccines and Diagnostics and Consumer Health......207